Doxycycline- and tetracycline-regulated transcriptional silencer enhance the expression level and transactivating performance of rtTA

Journal of Gene Medicine

Volumn 6, Issue 12, 2004, Pages 1403-1413

  Lai, Jen Feng ^a   Cheng, Hsin Yuan ^a   Cheng, Tzu Ling ^a   Lin, Yu Yu ^a   Chen, Li Chieh ^a   Lin, Mau Ting ^a   Jou, Tzuu Shuh ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Gene therapy; Reverse type tetracycline regulated transcriptional activator (rtTA); Tetracycline regulated transcriptional silencer (tTS); Ubiquitin proteasome pathway; Ubiquitination

Indexed keywords

DOXYCYCLINE; TETRACYCLINE; UBIQUITIN;

ARTICLE; DRUG DESIGN; DRUG SENSITIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SILENCER ELEMENT; TRANSACTIVATION; WESTERN BLOTTING;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOTTING, WESTERN; DOGS; DOXYCYCLINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENE THERAPY; GENETIC VECTORS; IMMUNOBLOTTING; KIDNEY; LUCIFERASES; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEASOME ENDOPEPTIDASE COMPLEX; SILENCER ELEMENTS, TRANSCRIPTIONAL; TETRACYCLINE; TRANS-ACTIVATORS; UBIQUITIN;

EID: 14244260723     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.614     Document Type: Article

References (20)

1. Baron U, Bujard H. Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol 2000; 327: 401-421.
2. Berens C, Hillen W. Gene regulation by tetracyclines. Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes. Eur J Biochem 2003; 270: 3109-3121.
3. Gossen M, Bujard H. Studying gene function in eukaryotes by conditional gene inactivation. Annu Rev Genet 2002; 36: 153-173.
4. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992; 89: 5547-5551.
5. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
6. Furth PA, St Onge L, Boger H, et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A 1994; 91: 9302-9306.
7. Lee P, Morley G, Huang Q, et al. Conditional lineage ablation to model human diseases. Proc Natl Acad Sci U S A 1998; 95: 11 371-11 376.
8. Deuschle U, Meyer WK, Thiesen HJ. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol 1995; 15: 1907-1914.
9. Forster K, Helbl V, Lederer T, Urlinger S, Wittenburg N, Hillen W. Tetracycline-inducible expression systems with reduced basal activity in mammalian cells. Nucleic Acids Res 1999; 27: 708-710.
10. Freundlieb S, Schirra-Muller C, Bujard H. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1999; 1: 4-12.
11. Rossi FM, Guicherit OM, Spicher A, et al. Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat Genet 1998; 20: 389-393.
12. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 2000; 97: 7963-7968.
13. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82: 373-428.
14. Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 1995; 92: 10 599-10 603.
15. Chen Z, Hagler J, Palombella VJ, et al. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 1995; 9: 1586-1597.
16. DiDonato JA, Mercurio F, Karin M, et al. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol Cell Biol 1995; 15: 1302-1311.
17. Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci U S A 1995; 92: 11 259-11 263.
18. Lamartina S, Roscilli G, Rinaudo CD, et al. Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. Hum Gene Ther 2002; 13: 199-210.
19. Knott A, Garke K, Urlinger S, et al. Tetracycline-dependent gene regulation: combinations of transregulators yield a variety of expression windows. BioTechniques 2002; 32 796-806.
20. Gill G, Ptashne M. Negative effect of the transcriptional activator GAL4. Nature 1988; 334: 721-724.